Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...

CEO Ron Kruszewski and Yahoo Finance Executive Editor Brian Sozzi at the 2025 World Economic Forum in Davos, Switzerland, to talk about the macro issues impacting the investment banking firm, ...

Thursday, January 23, 2025, marks the release of a new report by Stifel analysts on the US transport sector. The report outlines a cautious perspective on the industry's future, noting that while 2024 ...

Stifel raised the firm’s price target on Saia (SAIA) to $529 from $443 and keeps a Hold rating on the shares. 2024 largely proved to be “the ...

Stifel raised the firm’s price target on Old Dominion (ODFL) to $193 from $176 and keeps a Hold rating on the shares. 2024 largely proved to be ...

Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...

Stifel CEO Ron Kruszewski discusses banks' M&A space and market valuation ahead of the new US administration's policy. Kruszewski speaks to Bloomberg's Lisa Abramowicz on the sidelines of the 2025 ...

Equities researchers at Stifel Canada lifted their FY2024 earnings per share (EPS) estimates for shares of Kits Eyecare in a research note issued on Monday, January 20th. Stifel Canada analyst M.

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.

Down 15-2 just a few minutes into their contest, it would take a monumental effort for the Wheeling Central Maroon Knights to ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...